GlassScriptPhysician profile
Sami Muhammad Khan
NPI 1467816884
$1,046.05
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $687.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $186.92 | 2019-2020 | |
| Astellas Pharma US INC | $151.06 | 2020 | |
| Allergan, INC. | $117.91 | 2020 | |
| Merck Sharp & Dohme LLC | $103.71 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.85 | 2019-2020 | |
| Novo Nordisk INC | $63.02 | 2019-2020 | |
| Amarin Pharma, INC. | $55.88 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $42.38 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $29.64 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $26.47 | 2019 | |
| Glaxosmithkline, LLC. | $24.62 | 2020 | |
| Lilly USA, LLC | $23.69 | 2019-2020 | |
| Si-Bone, INC. | $23.05 | 2020 | |
| Janssen Pharmaceuticals, INC | $22.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.48 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $18.10 | 2020 | |
| Abbvie INC. | $16.60 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.71 | 2020 | |
| Alexion Pharmaceuticals, INC. | $11.77 | 2020 | |
| Daiichi Sankyo INC. | $11.69 | 2019 | |
| Pfizer INC. | $11.02 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.